Correlation Between Design Therapeutics and Collplant Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Collplant Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Collplant Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Collplant Biotechnologies, you can compare the effects of market volatilities on Design Therapeutics and Collplant Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Collplant Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Collplant Biotechnologies.
Diversification Opportunities for Design Therapeutics and Collplant Biotechnologies
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Design and Collplant is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Collplant Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collplant Biotechnologies and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Collplant Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collplant Biotechnologies has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Collplant Biotechnologies go up and down completely randomly.
Pair Corralation between Design Therapeutics and Collplant Biotechnologies
Given the investment horizon of 90 days Design Therapeutics is expected to generate 1.72 times more return on investment than Collplant Biotechnologies. However, Design Therapeutics is 1.72 times more volatile than Collplant Biotechnologies. It trades about 0.08 of its potential returns per unit of risk. Collplant Biotechnologies is currently generating about -0.09 per unit of risk. If you would invest 584.00 in Design Therapeutics on September 12, 2024 and sell it today you would earn a total of 106.00 from holding Design Therapeutics or generate 18.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Design Therapeutics vs. Collplant Biotechnologies
Performance |
| Timeline |
| Design Therapeutics |
| Collplant Biotechnologies |
Design Therapeutics and Collplant Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Design Therapeutics and Collplant Biotechnologies
The main advantage of trading using opposite Design Therapeutics and Collplant Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Collplant Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collplant Biotechnologies will offset losses from the drop in Collplant Biotechnologies' long position.| Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
| Collplant Biotechnologies vs. Keros Therapeutics | Collplant Biotechnologies vs. Merus BV | Collplant Biotechnologies vs. Vericel Corp Ord | Collplant Biotechnologies vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |